Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

Virtual healthcare provider Omada Health recently published findings from a consumer survey that aimed to gain insights into the experiences of users taking GLP-1 receptor agonists.

The attitudinal survey, which included 1,000 non-Omada members ages 21 to 75, examined the impact of GLP-1 medications across the patient journey, exploring people’s emotions and experiences before, during and after using the weight loss treatments.